The Post‘s editorial board cited several studies showing growing concern about uncertainty surrounding long COVID-19. Thirty percent of the 77 million COVID-19 survivors in the U.S. have had some sort of complication after infection, according to an American Academy of Physical Medicine and Rehabilitation model.
Another facet of long COVID-19 is mental health costs, as many with the condition struggle from its stigma and everyday living.
“Judging by the preliminary estimates, this poses an enormous future challenge for healthcare everywhere,” the board wrote. “There’s no time to waste. Research must find the causes and damage of long covid and lay preparations to treat it in all its manifestations.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
